I.J.A.M. Jonkers

High-Density vs Low-Density Lipoprotein Cholesterol as the Risk Factor for Coronary Artery Disease and Stroke in Old Age

Annelies W. E. Weverling‐Rijnsburger, I.J.A.M. Jonkers, Eric van Exel et al. · Archives of Internal Medicine · 2003 · 202 citations

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

I.J.A.M. Jonkers, Martina F Mohrschladt, Rudi G. J. Westendorp et al. · The American Journal of Medicine · 2002 · 167 citations

Insulin Resistance, Metabolic Syndrome, Obesity +12

Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil

I.J.A.M. Jonkers, A.H.M. Smelt, M. Ledeboer et al. · Gut · 2002 · 69 citations · Full text

Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG

I.J.A.M. Jonkers, A.H.M. Smelt, Hiroaki Hattori et al. · Journal of Lipid Research · 2003 · 42 citations · Full text

Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia

I.J.A.M. Jonkers, Frits H. de Man, Arnoud van der Laarse et al. · Journal of Hypertension · 2001 · 41 citations